Paul Hooper floating a GBM scorpion toxin drug, this morning.
Its just entered an initial Phase 1 trial. This particular scorpion toxin drug has been around since 2001 - moving from periodic pre clinic work in Beijing to the USA. ...now landed in Aust.
Up to a cap of $130m this morning.....on nearly 20 m shares traded.
In one Phase 1 trial - as of very recently......But no - our management doing a great job.
Weak investors here - look at yourself in the mirror, and do something about it - like talking to the CEO about the situation.
- Forums
- ASX - By Stock
- KZA
- Kazia Share Price
Kazia Share Price, page-377
-
- There are more pages in this discussion • 415 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)